Showing results (41-50 of 98) with videos related to
Sort By:
Pageof 10
JACC. Cardiovascular Interventions|November 21, 2009
Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention results from the STENT (strategic transcatheter evaluation of new therapies) groupBruce R Brodie, Hadley Wilson, Thomas Stuckey, et al.European Journal of Immunology|February 22, 2002
Relationship between kinetic stability and immunogenicity of HLA-DR4/peptide complexesFrances C Hall, Joshua D Rabinowitz, Robert Busch, et al.Journal of the American College of Cardiology|April 16, 2011
The acute hemodynamic effects of MitraClip therapyRobert J Siegel, Simon Biner, Asim M Rafique, et al.The American Journal of Cardiology|February 22, 2005
Influence of vessel diameter on the efficacy of distal protection devices during saphenous vein graft interventionAravind Swaminathan, Gregg W Stone, Campbell Rogers, et al.JACC. Cardiovascular Interventions|May 26, 2009
Outcomes and complications with off-label use of drug-eluting stents: results from the STENT (Strategic Transcatheter Evaluation of New Therapies) groupBruce R Brodie, Thomas Stuckey, William Downey, et al.Circulation|August 30, 2021
Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled TrialDhanunjaya Lakkireddy, David Thaler, Christopher R Ellis, et al.Journal of the American College of Cardiology|December 10, 2003
Prospective, randomized evaluation of thrombectomy prior to percutaneous intervention in diseased saphenous vein grafts and thrombus-containing coronary arteriesGregg W Stone, David A Cox, Joseph Babb, et al.Journal of the American College of Cardiology|April 20, 2005
Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation: analysis from the TAXUS-IV trialStephen G Ellis, Jeffrey J Popma, John M Lasala, et al.JACC. Cardiovascular Interventions|September 21, 2013
Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions)George D Dangas, Patrick W Serruys, Dean J Kereiakes, et al.Seminars in Thoracic and Cardiovascular Surgery|December 3, 2017
Complications After Self-expanding Transcatheter or Surgical Aortic Valve ReplacementJohn V Conte, James Hermiller, Jon R Resar, et al.Pageof 10